0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gamma Tubulin Antibody Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-20A13925
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gamma Tubulin Antibody Market Research Report 2023
BUY CHAPTERS

Global Gamma Tubulin Antibody Market Research Report 2025

Code: QYRE-Auto-20A13925
Report
May 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gamma Tubulin Antibody Market

The global market for Gamma Tubulin Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gamma Tubulin Antibody is an unconjugated antibody to Gamma Tubulin.
North American market for Gamma Tubulin Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gamma Tubulin Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Gamma Tubulin Antibody include Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., LifeSpan BioSciences, Inc, Abbexa, MyBiosource, Inc., Biorbyt, Creative Biolabs, GeneTex, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gamma Tubulin Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gamma Tubulin Antibody.
The Gamma Tubulin Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gamma Tubulin Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gamma Tubulin Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gamma Tubulin Antibody Market Report

Report Metric Details
Report Name Gamma Tubulin Antibody Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., LifeSpan BioSciences, Inc, Abbexa, MyBiosource, Inc., Biorbyt, Creative Biolabs, GeneTex, Arigo Biolaboratories Corp., Assay Genie, RayBiotech, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gamma Tubulin Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gamma Tubulin Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gamma Tubulin Antibody Market report?

Ans: The main players in the Gamma Tubulin Antibody Market are Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., LifeSpan BioSciences, Inc, Abbexa, MyBiosource, Inc., Biorbyt, Creative Biolabs, GeneTex, Arigo Biolaboratories Corp., Assay Genie, RayBiotech, Inc.

What are the Application segmentation covered in the Gamma Tubulin Antibody Market report?

Ans: The Applications covered in the Gamma Tubulin Antibody Market report are Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Other

What are the Type segmentation covered in the Gamma Tubulin Antibody Market report?

Ans: The Types covered in the Gamma Tubulin Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

Recommended Reports

Antibody Markets

Vaccine & Therapeutics

Immunoassays & Detection

1 Gamma Tubulin Antibody Market Overview
1.1 Product Definition
1.2 Gamma Tubulin Antibody by Type
1.2.1 Global Gamma Tubulin Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Gamma Tubulin Antibody by Application
1.3.1 Global Gamma Tubulin Antibody Market Value by Application (2024 VS 2031)
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Other
1.4 Global Gamma Tubulin Antibody Market Size Estimates and Forecasts
1.4.1 Global Gamma Tubulin Antibody Revenue 2020-2031
1.4.2 Global Gamma Tubulin Antibody Sales 2020-2031
1.4.3 Global Gamma Tubulin Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gamma Tubulin Antibody Market Competition by Manufacturers
2.1 Global Gamma Tubulin Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gamma Tubulin Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gamma Tubulin Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gamma Tubulin Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gamma Tubulin Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gamma Tubulin Antibody, Product Type & Application
2.7 Global Key Manufacturers of Gamma Tubulin Antibody, Date of Enter into This Industry
2.8 Global Gamma Tubulin Antibody Market Competitive Situation and Trends
2.8.1 Global Gamma Tubulin Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gamma Tubulin Antibody Players Market Share by Revenue
2.8.3 Global Gamma Tubulin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gamma Tubulin Antibody Market Scenario by Region
3.1 Global Gamma Tubulin Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gamma Tubulin Antibody Sales by Region: 2020-2031
3.2.1 Global Gamma Tubulin Antibody Sales by Region: 2020-2025
3.2.2 Global Gamma Tubulin Antibody Sales by Region: 2026-2031
3.3 Global Gamma Tubulin Antibody Revenue by Region: 2020-2031
3.3.1 Global Gamma Tubulin Antibody Revenue by Region: 2020-2025
3.3.2 Global Gamma Tubulin Antibody Revenue by Region: 2026-2031
3.4 North America Gamma Tubulin Antibody Market Facts & Figures by Country
3.4.1 North America Gamma Tubulin Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gamma Tubulin Antibody Sales by Country (2020-2031)
3.4.3 North America Gamma Tubulin Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gamma Tubulin Antibody Market Facts & Figures by Country
3.5.1 Europe Gamma Tubulin Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gamma Tubulin Antibody Sales by Country (2020-2031)
3.5.3 Europe Gamma Tubulin Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gamma Tubulin Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Gamma Tubulin Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gamma Tubulin Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Gamma Tubulin Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gamma Tubulin Antibody Market Facts & Figures by Country
3.7.1 Latin America Gamma Tubulin Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gamma Tubulin Antibody Sales by Country (2020-2031)
3.7.3 Latin America Gamma Tubulin Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gamma Tubulin Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Gamma Tubulin Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gamma Tubulin Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gamma Tubulin Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gamma Tubulin Antibody Sales by Type (2020-2031)
4.1.1 Global Gamma Tubulin Antibody Sales by Type (2020-2025)
4.1.2 Global Gamma Tubulin Antibody Sales by Type (2026-2031)
4.1.3 Global Gamma Tubulin Antibody Sales Market Share by Type (2020-2031)
4.2 Global Gamma Tubulin Antibody Revenue by Type (2020-2031)
4.2.1 Global Gamma Tubulin Antibody Revenue by Type (2020-2025)
4.2.2 Global Gamma Tubulin Antibody Revenue by Type (2026-2031)
4.2.3 Global Gamma Tubulin Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Gamma Tubulin Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gamma Tubulin Antibody Sales by Application (2020-2031)
5.1.1 Global Gamma Tubulin Antibody Sales by Application (2020-2025)
5.1.2 Global Gamma Tubulin Antibody Sales by Application (2026-2031)
5.1.3 Global Gamma Tubulin Antibody Sales Market Share by Application (2020-2031)
5.2 Global Gamma Tubulin Antibody Revenue by Application (2020-2031)
5.2.1 Global Gamma Tubulin Antibody Revenue by Application (2020-2025)
5.2.2 Global Gamma Tubulin Antibody Revenue by Application (2026-2031)
5.2.3 Global Gamma Tubulin Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Gamma Tubulin Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sino Biological, Inc.
6.1.1 Sino Biological, Inc. Company Information
6.1.2 Sino Biological, Inc. Description and Business Overview
6.1.3 Sino Biological, Inc. Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sino Biological, Inc. Gamma Tubulin Antibody Product Portfolio
6.1.5 Sino Biological, Inc. Recent Developments/Updates
6.2 Cell Signaling Technology, Inc.
6.2.1 Cell Signaling Technology, Inc. Company Information
6.2.2 Cell Signaling Technology, Inc. Description and Business Overview
6.2.3 Cell Signaling Technology, Inc. Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cell Signaling Technology, Inc. Gamma Tubulin Antibody Product Portfolio
6.2.5 Cell Signaling Technology, Inc. Recent Developments/Updates
6.3 Bio-Techne
6.3.1 Bio-Techne Company Information
6.3.2 Bio-Techne Description and Business Overview
6.3.3 Bio-Techne Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bio-Techne Gamma Tubulin Antibody Product Portfolio
6.3.5 Bio-Techne Recent Developments/Updates
6.4 OriGene Technologies, Inc.
6.4.1 OriGene Technologies, Inc. Company Information
6.4.2 OriGene Technologies, Inc. Description and Business Overview
6.4.3 OriGene Technologies, Inc. Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 OriGene Technologies, Inc. Gamma Tubulin Antibody Product Portfolio
6.4.5 OriGene Technologies, Inc. Recent Developments/Updates
6.5 LifeSpan BioSciences, Inc
6.5.1 LifeSpan BioSciences, Inc Company Information
6.5.2 LifeSpan BioSciences, Inc Description and Business Overview
6.5.3 LifeSpan BioSciences, Inc Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 LifeSpan BioSciences, Inc Gamma Tubulin Antibody Product Portfolio
6.5.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.6 Abbexa
6.6.1 Abbexa Company Information
6.6.2 Abbexa Description and Business Overview
6.6.3 Abbexa Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abbexa Gamma Tubulin Antibody Product Portfolio
6.6.5 Abbexa Recent Developments/Updates
6.7 MyBiosource, Inc.
6.7.1 MyBiosource, Inc. Company Information
6.7.2 MyBiosource, Inc. Description and Business Overview
6.7.3 MyBiosource, Inc. Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MyBiosource, Inc. Gamma Tubulin Antibody Product Portfolio
6.7.5 MyBiosource, Inc. Recent Developments/Updates
6.8 Biorbyt
6.8.1 Biorbyt Company Information
6.8.2 Biorbyt Description and Business Overview
6.8.3 Biorbyt Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biorbyt Gamma Tubulin Antibody Product Portfolio
6.8.5 Biorbyt Recent Developments/Updates
6.9 Creative Biolabs
6.9.1 Creative Biolabs Company Information
6.9.2 Creative Biolabs Description and Business Overview
6.9.3 Creative Biolabs Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Creative Biolabs Gamma Tubulin Antibody Product Portfolio
6.9.5 Creative Biolabs Recent Developments/Updates
6.10 GeneTex
6.10.1 GeneTex Company Information
6.10.2 GeneTex Description and Business Overview
6.10.3 GeneTex Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GeneTex Gamma Tubulin Antibody Product Portfolio
6.10.5 GeneTex Recent Developments/Updates
6.11 Arigo Biolaboratories Corp.
6.11.1 Arigo Biolaboratories Corp. Company Information
6.11.2 Arigo Biolaboratories Corp. Description and Business Overview
6.11.3 Arigo Biolaboratories Corp. Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Arigo Biolaboratories Corp. Gamma Tubulin Antibody Product Portfolio
6.11.5 Arigo Biolaboratories Corp. Recent Developments/Updates
6.12 Assay Genie
6.12.1 Assay Genie Company Information
6.12.2 Assay Genie Description and Business Overview
6.12.3 Assay Genie Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Assay Genie Gamma Tubulin Antibody Product Portfolio
6.12.5 Assay Genie Recent Developments/Updates
6.13 RayBiotech, Inc.
6.13.1 RayBiotech, Inc. Company Information
6.13.2 RayBiotech, Inc. Description and Business Overview
6.13.3 RayBiotech, Inc. Gamma Tubulin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 RayBiotech, Inc. Gamma Tubulin Antibody Product Portfolio
6.13.5 RayBiotech, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gamma Tubulin Antibody Industry Chain Analysis
7.2 Gamma Tubulin Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gamma Tubulin Antibody Production Mode & Process Analysis
7.4 Gamma Tubulin Antibody Sales and Marketing
7.4.1 Gamma Tubulin Antibody Sales Channels
7.4.2 Gamma Tubulin Antibody Distributors
7.5 Gamma Tubulin Antibody Customer Analysis
8 Gamma Tubulin Antibody Market Dynamics
8.1 Gamma Tubulin Antibody Industry Trends
8.2 Gamma Tubulin Antibody Market Drivers
8.3 Gamma Tubulin Antibody Market Challenges
8.4 Gamma Tubulin Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Gamma Tubulin Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gamma Tubulin Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gamma Tubulin Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gamma Tubulin Antibody Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gamma Tubulin Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gamma Tubulin Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gamma Tubulin Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gamma Tubulin Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gamma Tubulin Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gamma Tubulin Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gamma Tubulin Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of Gamma Tubulin Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gamma Tubulin Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma Tubulin Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gamma Tubulin Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gamma Tubulin Antibody Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gamma Tubulin Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global Gamma Tubulin Antibody Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gamma Tubulin Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global Gamma Tubulin Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gamma Tubulin Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global Gamma Tubulin Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gamma Tubulin Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America Gamma Tubulin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gamma Tubulin Antibody Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gamma Tubulin Antibody Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gamma Tubulin Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gamma Tubulin Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gamma Tubulin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gamma Tubulin Antibody Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gamma Tubulin Antibody Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gamma Tubulin Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gamma Tubulin Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gamma Tubulin Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gamma Tubulin Antibody Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gamma Tubulin Antibody Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gamma Tubulin Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gamma Tubulin Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gamma Tubulin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gamma Tubulin Antibody Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gamma Tubulin Antibody Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gamma Tubulin Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gamma Tubulin Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gamma Tubulin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gamma Tubulin Antibody Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gamma Tubulin Antibody Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gamma Tubulin Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gamma Tubulin Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gamma Tubulin Antibody Sales (K Units) by Type (2020-2025)
 Table 51. Global Gamma Tubulin Antibody Sales (K Units) by Type (2026-2031)
 Table 52. Global Gamma Tubulin Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global Gamma Tubulin Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global Gamma Tubulin Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gamma Tubulin Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gamma Tubulin Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global Gamma Tubulin Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global Gamma Tubulin Antibody Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Gamma Tubulin Antibody Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Gamma Tubulin Antibody Sales (K Units) by Application (2020-2025)
 Table 61. Global Gamma Tubulin Antibody Sales (K Units) by Application (2026-2031)
 Table 62. Global Gamma Tubulin Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global Gamma Tubulin Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global Gamma Tubulin Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gamma Tubulin Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gamma Tubulin Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global Gamma Tubulin Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global Gamma Tubulin Antibody Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Gamma Tubulin Antibody Price (US$/Unit) by Application (2026-2031)
 Table 70. Sino Biological, Inc. Company Information
 Table 71. Sino Biological, Inc. Description and Business Overview
 Table 72. Sino Biological, Inc. Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sino Biological, Inc. Gamma Tubulin Antibody Product
 Table 74. Sino Biological, Inc. Recent Developments/Updates
 Table 75. Cell Signaling Technology, Inc. Company Information
 Table 76. Cell Signaling Technology, Inc. Description and Business Overview
 Table 77. Cell Signaling Technology, Inc. Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Cell Signaling Technology, Inc. Gamma Tubulin Antibody Product
 Table 79. Cell Signaling Technology, Inc. Recent Developments/Updates
 Table 80. Bio-Techne Company Information
 Table 81. Bio-Techne Description and Business Overview
 Table 82. Bio-Techne Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bio-Techne Gamma Tubulin Antibody Product
 Table 84. Bio-Techne Recent Developments/Updates
 Table 85. OriGene Technologies, Inc. Company Information
 Table 86. OriGene Technologies, Inc. Description and Business Overview
 Table 87. OriGene Technologies, Inc. Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. OriGene Technologies, Inc. Gamma Tubulin Antibody Product
 Table 89. OriGene Technologies, Inc. Recent Developments/Updates
 Table 90. LifeSpan BioSciences, Inc Company Information
 Table 91. LifeSpan BioSciences, Inc Description and Business Overview
 Table 92. LifeSpan BioSciences, Inc Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. LifeSpan BioSciences, Inc Gamma Tubulin Antibody Product
 Table 94. LifeSpan BioSciences, Inc Recent Developments/Updates
 Table 95. Abbexa Company Information
 Table 96. Abbexa Description and Business Overview
 Table 97. Abbexa Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Abbexa Gamma Tubulin Antibody Product
 Table 99. Abbexa Recent Developments/Updates
 Table 100. MyBiosource, Inc. Company Information
 Table 101. MyBiosource, Inc. Description and Business Overview
 Table 102. MyBiosource, Inc. Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. MyBiosource, Inc. Gamma Tubulin Antibody Product
 Table 104. MyBiosource, Inc. Recent Developments/Updates
 Table 105. Biorbyt Company Information
 Table 106. Biorbyt Description and Business Overview
 Table 107. Biorbyt Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biorbyt Gamma Tubulin Antibody Product
 Table 109. Biorbyt Recent Developments/Updates
 Table 110. Creative Biolabs Company Information
 Table 111. Creative Biolabs Description and Business Overview
 Table 112. Creative Biolabs Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Creative Biolabs Gamma Tubulin Antibody Product
 Table 114. Creative Biolabs Recent Developments/Updates
 Table 115. GeneTex Company Information
 Table 116. GeneTex Description and Business Overview
 Table 117. GeneTex Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. GeneTex Gamma Tubulin Antibody Product
 Table 119. GeneTex Recent Developments/Updates
 Table 120. Arigo Biolaboratories Corp. Company Information
 Table 121. Arigo Biolaboratories Corp. Description and Business Overview
 Table 122. Arigo Biolaboratories Corp. Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Arigo Biolaboratories Corp. Gamma Tubulin Antibody Product
 Table 124. Arigo Biolaboratories Corp. Recent Developments/Updates
 Table 125. Assay Genie Company Information
 Table 126. Assay Genie Description and Business Overview
 Table 127. Assay Genie Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Assay Genie Gamma Tubulin Antibody Product
 Table 129. Assay Genie Recent Developments/Updates
 Table 130. RayBiotech, Inc. Company Information
 Table 131. RayBiotech, Inc. Description and Business Overview
 Table 132. RayBiotech, Inc. Gamma Tubulin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. RayBiotech, Inc. Gamma Tubulin Antibody Product
 Table 134. RayBiotech, Inc. Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Gamma Tubulin Antibody Distributors List
 Table 138. Gamma Tubulin Antibody Customers List
 Table 139. Gamma Tubulin Antibody Market Trends
 Table 140. Gamma Tubulin Antibody Market Drivers
 Table 141. Gamma Tubulin Antibody Market Challenges
 Table 142. Gamma Tubulin Antibody Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gamma Tubulin Antibody
 Figure 2. Global Gamma Tubulin Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gamma Tubulin Antibody Market Share by Type: 2024 & 2031
 Figure 4. Monoclonal Antibody Product Picture
 Figure 5. Polyclonal Antibody Product Picture
 Figure 6. Global Gamma Tubulin Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gamma Tubulin Antibody Market Share by Application: 2024 & 2031
 Figure 8. Flow Cytometry
 Figure 9. ELISA
 Figure 10. Western Blot
 Figure 11. Immunoprecipitation
 Figure 12. Immunofluorescence
 Figure 13. Other
 Figure 14. Global Gamma Tubulin Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Gamma Tubulin Antibody Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Gamma Tubulin Antibody Sales (2020-2031) & (K Units)
 Figure 17. Global Gamma Tubulin Antibody Average Price (US$/Unit) & (2020-2031)
 Figure 18. Gamma Tubulin Antibody Report Years Considered
 Figure 19. Gamma Tubulin Antibody Sales Share by Manufacturers in 2024
 Figure 20. Global Gamma Tubulin Antibody Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Gamma Tubulin Antibody Players: Market Share by Revenue in Gamma Tubulin Antibody in 2024
 Figure 22. Gamma Tubulin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Gamma Tubulin Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Gamma Tubulin Antibody Sales Market Share by Country (2020-2031)
 Figure 25. North America Gamma Tubulin Antibody Revenue Market Share by Country (2020-2031)
 Figure 26. United States Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Gamma Tubulin Antibody Sales Market Share by Country (2020-2031)
 Figure 29. Europe Gamma Tubulin Antibody Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Gamma Tubulin Antibody Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Gamma Tubulin Antibody Revenue Market Share by Region (2020-2031)
 Figure 37. China Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Gamma Tubulin Antibody Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Gamma Tubulin Antibody Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Gamma Tubulin Antibody Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Gamma Tubulin Antibody Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Gamma Tubulin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Gamma Tubulin Antibody by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Gamma Tubulin Antibody by Type (2020-2031)
 Figure 56. Global Gamma Tubulin Antibody Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Gamma Tubulin Antibody by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Gamma Tubulin Antibody by Application (2020-2031)
 Figure 59. Global Gamma Tubulin Antibody Price (US$/Unit) by Application (2020-2031)
 Figure 60. Gamma Tubulin Antibody Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI